Francesco Bellini
38Patents
11h-index
24Co-inventors
75Inventor score
Filing activity: Mar 19, 1979 → Dec 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4439617A | N-Naphthoylglycine derivatives | Chemistry; Metallurgy | 34 | Expired |
| US8632822B2 | Combination of an oxidant and a photoactivator for the healing of wounds | Human Necessities | 28 | Active |
| US8637086B2 | Method for acne treatment using an oxidative-photoactivated composition | Human Necessities | 27 | Active |
| US8658219B2 | Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin | Human Necessities | 27 | Active |
| US8911791B2 | Method for acne treatment using an oxidative-photoactivated composition | Human Necessities | 25 | Active |
| US8986745B2 | Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin | Human Necessities | 23 | Active |
| US8974833B2 | Combination of an oxidant and a photoactivator for the healing of wounds | Human Necessities | 23 | Active |
| US4568693A | N-Naphthoylglycine derivatives | Chemistry; Metallurgy | 18 | Expired |
| US4391816A | N-(Naphthalenylthioxomethyl)aminoacid derivatives | Chemistry; Metallurgy | 14 | Expired |
| US4391825A | N-[[6-(Lower alkoxy)-5-(trifluoromethylthio)-1-naphthalenyl]thioxomethyl]-N-(lower alkyl)glycines | Chemistry; Metallurgy | 12 | Expired |
| US4216209A | Tripeptide angiotensin converting enzyme inhibitors | Emerging Cross-Sectional Technologies | 12 | Expired |
| US4600724A | N-naphthoylglycine derivatives | Chemistry; Metallurgy | 11 | Expired |
| US9375446B2 | Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin | Human Necessities | 10 | Active |
| US4244947A | Carba decapeptide derivatives of [TYR.sup.6 ]-somatostatin | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4672058A | N[[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]-thioxomethyl]-N -methylglycinamides | Chemistry; Metallurgy | 7 | Expired |
| US4604406A | N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their thionaphthoyl analogs | Human Necessities | 6 | Expired |
| US4408077A | 6-(Lower alkoxy)-5-(trifluoromethyl)-1-naphthalenecarboxaldehydes | Chemistry; Metallurgy | 5 | Expired |
| US10610513B2 | Biophotonic compositions for the treatment of otitis externa | Human Necessities | 2 | Active |
| US4301066A | Preparation of (D-Trp .sup.6)-LH-RH via the heptapeptide H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH.sub.2 | Emerging Cross-Sectional Technologies | 2 | Expired |
| US4547516A | Antisecretory agents derived from meldrum's acid | Chemistry; Metallurgy | 1 | Expired |
| US10149985B2 | Methods and compositions for treating rosacea | Human Necessities | 1 | Active |
| US4446150A | Naphthalenylthiazole derivatives | Human Necessities | 1 | Expired |
| US4499310A | 5-Methyl-1-(trifluoromethyl)-2-naphthalenol, process for its preparation and ethers thereof | Chemistry; Metallurgy | 1 | Expired |
| US10485986B2 | Methods and compositions for treatment of pigmented lesions | Human Necessities | 0 | Active |
| US4946987A | N-naphthoylglycine derivatives | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.